全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Neck Dissection for Thoracic Esophageal Squamous Cell Carcinoma

DOI: 10.1155/2012/750456

Full-Text   Cite this paper   Add to My Lib

Abstract:

Subtotal esophagectomy with extended lymph node dissection is a standard procedure for thoracic esophageal squamous cell carcinoma. Three-field lymphadenectomy, including neck dissection, is a standard type of lymph node dissection for complete clearance of tumor cells. Based on various series of analyses for lymph node metastases, the appropriate indication for neck dissection has been clarified. Herein, we describe the established techniques of neck dissection and review recent topics of three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. 1. Introduction Neck dissection was introduced in the early 1980s based on analyses of the spreading pattern of lymph node metastases from thoracic esophageal squamous cell carcinoma (SCC) [1, 2]. Extended lymph node dissection including neck, mediastinal, and abdominal lymph nodes has been called three-field lymph node dissection (3FLD) [3]. The neck dissection includes cervical paraesophageal nodes, deep cervical nodes, and supraclavicular nodes, and it was subsequently adopted as the standard surgical procedure for thoracic esophageal SCC at high-volume centers in Japan in the late 1980s [4, 5]. A similar surgical procedure was also introduced in Western nations in the late 1990s [6, 7]. 2. Indications for Neck Dissection Despite recent advances in preoperative staging, including computed tomography, positron emission tomography, and ultrasonography, the pathological findings after 3FLD indicate that the overall accuracy, sensitivity, and specificity of clinical staging remain too low. More than 75% of cervical metastases are not detected before surgery. Therefore, the indication for neck dissection should be determined by tumor location, tumor depth, and/or intraoperative nodal assessment of recurrent nerve nodes. A summary of the prevalence of positive cases of cervical lymph node metastases and overall 5-year survival after 3FLD is shown in Table 1. Table 1: Positive rates of cervical lymph node metastases and overall five-year survival rates after three-field lymph node dissection. The prevalence of positive cervical lymph nodes associated with tumors in the upper part of the thoracic esophagus was significantly higher than that derived from tumors in the lower part of the esophagus (upper, 48%; middle, 28%; lower, 13%) [4]. Among the patients with lower third esophageal tumors, none of those with T1b tumors had cervical metastasis, whereas 16% of those with T2-T4 tumors did. Moreover, 29% of patients with tumors in the upper third of the esophagus had initial lymph node

References

[1]  Y. Sannohe, R. Hiratsuka, and K. Doki, “Lymph node metastases in cancer of the thoracic esophagus,” American Journal of Surgery, vol. 141, no. 2, pp. 216–218, 1981.
[2]  H. Shimada, Y. Nabeya, H. Matsubara et al., “Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers,” American Journal of Surgery, vol. 191, no. 2, pp. 250–254, 2006.
[3]  K. Isono, H. Sato, and K. Nakayama, “Results of a nationwide study on the three-field lymph node dissection of esophageal cancer,” Oncology, vol. 48, no. 5, pp. 411–420, 1991.
[4]  H. Shimada, S. I. Okazumi, H. Matsubara et al., “Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection,” World Journal of Surgery, vol. 30, no. 8, pp. 1441–1449, 2006.
[5]  H. Akiyama, M. Tsurumaru, T. Kawamura, and Y. Ono, “Principles of surgical treatment for carcinoma of the esophagus,” Annals of Surgery, vol. 194, no. 4, pp. 438–446, 1981.
[6]  N. Altorki, M. Kent, C. Ferrara, and J. Port, “Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus,” Annals of Surgery, vol. 236, no. 2, pp. 177–183, 2002.
[7]  T. Lerut, P. Nafteux, J. Moons et al., “Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma,” Annals of Surgery, vol. 240, no. 6, pp. 962–974, 2004.
[8]  H. Shiozaki, M. Yano, T. Tsujinaka et al., “Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer,” Diseases of the Esophagus, vol. 14, no. 3-4, pp. 191–196, 2001.
[9]  Y. Tachimori, Y. Nagai, N. Kanamori, N. Hokamura, and H. Igaki, “Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system,” Diseases of the Esophagus, vol. 24, no. 1, pp. 33–38, 2011.
[10]  H. Kato, H. Watanabe, Y. Tachimori, and T. Iizuka, “Evaluation of neck lymph node dissection for thoracic esophageal carcinoma,” Annals of Thoracic Surgery, vol. 51, no. 6, pp. 931–935, 1991.
[11]  T. Nishihira, K. Hirayama, and S. Mori, “A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus,” American Journal of Surgery, vol. 175, no. 1, pp. 47–51, 1998.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133